Healthcare Technology Report August 30, 2024
Certara, a renowned global leader in model-informed drug development, has signed a definitive agreement to acquire Chemaxon, a prominent provider of cheminformatics software. Chemaxon’s software products are widely used for chemical structure drawing, property prediction, and analysis. These products assist research scientists worldwide in the digitization of the design, create, test, and analyze lifecycle, which is essential for the discovery of new chemical leads.
A decade-long partnership has been...
Today's Sponsors
Today's Sponsor